Cargando…
Bone Health History in Breast Cancer Patients on Aromatase Inhibitors
A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis, which may impact fracture risk after AI therapy and choice of initial hormonal therapy. A total of 2,157 invasive BC patients initially treated with an AI wer...
Autores principales: | Kwan, Marilyn L., Lo, Joan C., Tang, Li, Laurent, Cecile A., Roh, Janise M., Chandra, Malini, Hahn, Theresa E., Hong, Chi-Chen, Sucheston-Campbell, Lara, Hershman, Dawn L., Quesenberry, Charles P., Ambrosone, Christine B., Kushi, Lawrence H., Yao, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213031/ https://www.ncbi.nlm.nih.gov/pubmed/25354083 http://dx.doi.org/10.1371/journal.pone.0111477 |
Ejemplares similares
-
Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study
por: Greenlee, Heather, et al.
Publicado: (2014) -
Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy
por: Lo, Joan C., et al.
Publicado: (2021) -
Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study
por: Anyene, Ijeamaka C., et al.
Publicado: (2021) -
Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables
por: Wang, Zinian, et al.
Publicado: (2020) -
SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data
por: Liu, Qian, et al.
Publicado: (2019)